Mercado de Terapêutica direcionada ao RNA ANÁLISE DE TAMANHO E PARTICIPAÇÃO - TENDÊNCIAS DE CRESCIMENTO E PREVISÕES (2024 - 2031)
RNA Targeted Therapeutics Market is Segmented By Type of Target Molecule (Cap Binding Complex, CDKL5, Dystrophin Protein, Erα, G542X, MNK1 / MNK2, PAX6 gene, SMN2), Por Tipo de Abordagem (Indirect RNA Targeting: Epitranscriptomics, mRNA Translation Modulation, RNA Splicing Modification East America), Ásia O relatório oferece o valor (em USD bilhões) para os segmentos acima mencionados.
Competitive overview of Mercado de Terapêutica direcionada ao RNA
Os principais jogadores que operam no mercado terapêutico visado do RNA incluem Abivax, AC Immune, Arrakis Therapeutics, eFFECTOR Therapeutics, Eloxx Pharmaceuticals, H3 Biomedicina, PTC Therapeutics, Ribometrix, Skyhawk Therapeutics e STORM Therapeutics.
Mercado de Terapêutica direcionada ao RNA Leaders
- Abivax
- AC Imune
- Arrakis Terapêutica
- EFEITOS Terapias
- Farmacêutica Eloxx
*Disclaimer: Major players are listed in no particular order.
Mercado de Terapêutica direcionada ao RNA - Competitive Rivalry, 2023
Mercado de Terapêutica direcionada ao RNA
Market Consolidated
(Dominated by major players)
(Dominated by major players)
Market Fragmented
(Highly competitive with lots of players.)
(Highly competitive with lots of players.)
*Source: Coherent Market Insights